SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
PDL BIOPHARMA
(NQNM:PDLI Last Sale: 3.44 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (PDLI : $3.44)
$425,156 million Market Cap at Market Close, July 1, 2022
Employs 900.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
1400 Seaport Boulevard Research Report World View
Redwood City, CA 94063 Fact Sheet Earnings Snapshot - Last 08/18/18
Phone: (510) 574-1400 Financial Statements
Peer Comparison
Annual Reports

Karen A. Dawes, Chmn., L. Patrick Gage, Interim CEO, Andrew L. Guggenhime, CFO
Develops human and humanized antibodies and other potential drugs to prevent or treat certain disease conditions, including viral infections and cancer. Formerly PROTEIN DESIGN LABS INC until January 9, 2006. Announced spin off and separate listing of biotechnology business, April 10, 2008, and paid a special dividend of $500 million, $4.25 per share, May 5, 2008. Spin-out of FACET BIOTECH CORP (FACT) effective December 18, 2008, when-issued trading as (FACTV) started December 10, 2008.
Historical Charts    Technical Analysis
No Historical Data available for PDLI

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common PDLI $3.44 $3.44 0 .0 $3.3 $3.49 2,102,685 $3.3 $3.49 123,591,824
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $425,155,875

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
09-OCT-01 PDLI Split 2 for 1
22-AUG-00 PDLI Split 2 for 1

A488
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex